Increased low density lipoprotein oxidation in stable kidney transplant recipients (scientific article published on 01 February 1996)

De novo development of hypercholesterolemia and elevated high-density lipoprotein cholesterol: apoprotein A-I ratio in patients with chronic renal failure following kidney transplantation

Q70456647

Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B

Q70666068

Autoantibodies against malondialdehyde-modified LDL are elevated in subjects with an LDL subclass pattern B

Q72028528

Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis

Q72898129

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man

Q28359675

Prediction of creatinine clearance from serum creatinine

Q29615603

Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia

Q30011260

Very low density and low density lipoprotein subfractions in type III and type IV hyperlipoproteinemia Chemical and physical properties

Q34001590

Separation of plasma lipoproteins by density-gradient ultracentrifugation

Q34566105

Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease

Q39756771

Fractionation of human low density lipoprotein by column chromatography

Q40047553

Hyperlipidemia After Renal Transplantation: Natural History and Pathophysiology

Q41103475

Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits

Q43652291

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

Q44144342

Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.

Q46150836

Enhanced macrophage degradation of biologically modified low density lipoprotein.

Q46543466

Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease.

Q51595673

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

Q59704366

Oxygen free radicals and platelet and granulocyte aggregability in renal transplant patients

Q61831239

Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man

Q67516427

Risk factors for accelerated atherosclerosis in renal transplant recipients

Q68142393

Persistent hyperlipidemia in renal transplant patients

Q68163915

Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects

Q68204961

P433

issue

P407

language of work or name

English

Q1860

P304

page(s)

488-493

P577

publication date

1996-02-01

P1433

published in

Kidney International

Q6404823

P1476

title

Increased low density lipoprotein oxidation in stable kidney transplant recipients

P478

volume

Reverse relations

cites work (P2860)

Q43737731	Alpha-tocopherol and probucol reduce autoantibody titer to MDA-LDL in hypercholesterolemic rabbits
Q33661571	Are there markers to initiate treatment of chronic rejection?
Q30490221	Astaxanthin vs placebo on arterial stiffness, oxidative stress and inflammation in renal transplant patients (Xanthin): a randomised controlled trial.
Q34417640	Calcineurin inhibitors and post-transplant hyperlipidaemias
Q38177489	Cardiovascular complications after transplantation: treatment options in solid organ recipients
Q57750639	Cardiovascular disease in renal transplantation: Management by statins
Q30490204	Comparison of markers of oxidative stress, inflammation and arterial stiffness between incident hemodialysis and peritoneal dialysis patients--an observational study.
Q73338102	Conversion from cyclosporine A to azathioprine treatment improves LDL oxidation in kidney transplant recipients
Q46873899	Effect of calcineurin inhibitors on low-density lipoprotein oxidation
Q61864856	Fatty acid composition in low-density lipoproteins from renal transplant recipients
Q86978354	Fluvastatin Decreases Oxidative Stress in Kidney Transplant Patients
Q33542770	Immunologic and nonimmunologic risk factors of chronic rejection
Q48031492	Inflammation and oxidation: do they improve after kidney transplantation? Relationship with mortality after transplantation.
Q44279990	Lipoprotein-apolipoprotein changes in renal transplant recipients
Q45958503	Low-density lipoprotein oxidizability and the alteration of its fatty acid content in renal transplant recipients treated with cyclosporine/tacrolimus.
Q74617448	No clinical evidence of hyperlipidemia as a risk factor for chronic renal allograft failure
Q61864861	Oxidation of low-density lipoproteins in renal transplant recipients
Q43963175	Oxidation of low-density lipoproteins in renal transplant recipients treated with tacrolimus.
Q45059825	Oxidative stress and coenzyme Q10 supplementation in renal transplant recipients
Q77176695	Oxidizability of low-density lipoproteins from Neoral and tacrolimus-treated renal transplant patients
Q34310277	Pathophysiology of oxidative stress in diabetes mellitus
Q73667609	Pathophysiology of the progression of renal graft dysfunction
Q28076119	Post-transplant dyslipidemia: Mechanisms, diagnosis and management
Q77725302	Postischemic reperfusion injury and allograft arteriosclerosis
Q43805962	Serum lipid metabolism abnormalities and change in lipoprotein contents in patients with advanced-stage renal disease
Q44829177	Studies of LDL particle size and susceptibility to oxidation and association with glucose metabolism in children after heart transplantation
Q33781416	The effects of lipids on graft outcome
Q73219424	The relative influence of antigen-dependent and independent factors for development and progression of chronic rejection
Q90332833	Trained immunity in organ transplantation